Dementia rates have declined over the past dozen years, but some of the most promising treatments for a leading cause, Alzheimer's disease, are failing to live up to expectations, Tabitha M. Powledge writes: "Despite these continuing disappointments, will the hunt for a magic bullet against Alzheimer’s disease continue? You bet. Medicare is now spending around 20% of its funds on caring for Alzheimer’s patients. Not to mention that the profit potential is ginormous."
November 26, 2016